Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)
Stricter Rules Are Shrinking Banks
48:09 - Feb. 27 -- On “Before The Bell,” Bloomberg’s Betty Liu, Matt Miller and Olivia Sterns report on today’s top trending news stories. They speak on “In The Loop.”
  • The Battle for a Cuban Rum Brand
  • Build a Brand, Not Just a Car: Zenvo Survival Plan
  • Samsung Introducing Latest 3-Sided Galaxy S Devices